Physicians' Academy for Cardiovascular Education

PCSK9 inhibition: Novel insights into a new therapeutic approach for the lowering of LDL-C: the PCSK9 saga

Sep. 9, 2014

Presentation by prof. Evan Stein, MD, Cincinnati, OH, USA at PACE symposium 'Innovations in lipid management: Evolving insights and implications from PCSK9 research' on August 30, 2014 at ESC in Barcelona
 
Download PCSK9 inhibition - Novel insights into a new therapeutic approach fo the lwoering of LDL-C - The PCSK9 saga. dr Stein.pdf
 

To view slides, click on images